Literature DB >> 34699627

Tumor-Microenvironment-Activated Reactive Oxygen Species Amplifier for Enzymatic Cascade Cancer Starvation/Chemodynamic /Immunotherapy.

Man Wang1, Mengyu Chang2, Chunxia Li1, Qing Chen1, Zhiyao Hou3, Bengang Xing4, Jun Lin2.   

Abstract

At present, some progress has been made in the field of cancer theranostics based on nanocatalysts (NCs), but achieving precise theranostics in response to the specific tumor microenvironment (TME) remains a major challenge. Herein, a TME-responsive upconversion nanoparticles (UCNPs)-based smart UCNPs@Cu-Cys-GOx (UCCG) nanosystem is engineered, which combines natural enzymes and nanozymes so as to amplify reactive oxygen species (ROS) generation in situ for cancer starvation/chemodynamic/immunotherapy. One of the biggest merits of this material is that it can be preserved inert (off) in normal tissues, and only in the TME can it be specifically activated (on) through a series of enzymatic cascades to boost ROS production via a strategy of open source (H2 O2 self-supplying ability) and reduce expenditure (glutathione (GSH) consuming ability). More importantly, the enhanced oxidative stress by UCCG NCs reverses the immunosuppressive TME, and facilitates antitumor immune responses. Meanwhile, the starvation/chemodynamic synergistic therapy triggered by UCCG combined with PD-L1 antibody effectively inhibits the growth of primary tumors and cancer metastasis. In addition, the UCNPs in UCCG present upconversion luminescence enhancement, which can be exploited to visualize the reinforced ROS generation in real time. Collectively, this work provides an original method for the devising and exploitation of UCNPs-based catalytic immunotherapy.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  ROS amplifiers; enzymatic cascade reactions; immune system activation; synergistic therapy; upconversion luminescence

Mesh:

Substances:

Year:  2021        PMID: 34699627     DOI: 10.1002/adma.202106010

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  4 in total

Review 1.  Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Authors:  Zhiyan Li; Xianghui Li; Shichao Ai; Song Liu; Wenxian Guan
Journal:  Int J Nanomedicine       Date:  2022-06-17

2.  3D printed hydrogel scaffolds combining glutathione depletion-induced ferroptosis and photothermia-augmented chemodynamic therapy for efficiently inhibiting postoperative tumor recurrence.

Authors:  Wentao Dang; Wei-Chih Chen; Enguo Ju; Yanteng Xu; Kai Li; Haixia Wang; Kun Wang; Shixian Lv; Dan Shao; Yu Tao; Mingqiang Li
Journal:  J Nanobiotechnology       Date:  2022-06-07       Impact factor: 9.429

3.  GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma.

Authors:  Jiahui Han; Xinzhou Deng; Renhuang Sun; Ming Luo; Meng Liang; Bing Gu; Te Zhang; Zhen Peng; Ying Lu; Chao Tian; Yutao Yan; Zhiguo Luo
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

4.  GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis.

Authors:  Jie Zeng; Jianing Yi; Siyi Tan; Yuanjun Zeng; Lianhong Zou; Chaojie Zhang; Luyao Liu; Pingyong Yi; Peizhi Fan; Jie Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-28       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.